These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1725890)

  • 1. Effects of the potassium channel activator, cromakalim, on arterial and cardiac responses to norepinephrine, angiotensin II, and isoproterenol in normotensive men.
    von Nguyen P; Holliwell DL; Davis A; Tasker TC; Leenen FH
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):797-806. PubMed ID: 1725890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of renin secretion by potassium-channel activation with cromakalim.
    Ferrier CP; Kurtz A; Lehner P; Shaw SG; Pusterla C; Saxenhofer H; Weidmann P
    Eur J Clin Pharmacol; 1989; 36(5):443-7. PubMed ID: 2666140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical studies with the potassium channel activator cromakalim in normotensive and hypertensive subjects.
    Donnelly R; Elliott HL; Meredith PA; Reid JL
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):790-5. PubMed ID: 1703602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific but differential antagonism by glibenclamide of the vasodepressor effects of cromakalim and nicorandil in spinally-anaesthetized dogs.
    Yamada H; Yoneyama F; Satoh K; Taira N
    Br J Pharmacol; 1990 Jul; 100(3):413-6. PubMed ID: 2143956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models.
    Clapham JC; Hamilton TC; Longman SD; Buckingham RE; Campbell CA; Ilsley GL; Gout B
    Arzneimittelforschung; 1991 Apr; 41(4):385-91. PubMed ID: 1907150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potassium channel opening drug cromakalim produces arterioselective vasodilation in the upper limbs of healthy volunteers.
    Webb DJ; Benjamin N; Vallance P
    Br J Clin Pharmacol; 1989 Jun; 27(6):757-61. PubMed ID: 2757892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical pharmacology of Ro 31-6930, a new potassium channel opener.
    Paciorek PM; Burden DT; Burke YM; Cowlrick IS; Perkins RS; Taylor JC; Waterfall JF
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):188-97. PubMed ID: 1689412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in trachealis muscle: electrophysiological and mechanical studies in guinea-pig tissue.
    Cook SJ; Small RC; Berry JL; Chiu P; Downing SJ; Foster RW
    Br J Pharmacol; 1993 Aug; 109(4):1140-8. PubMed ID: 8104643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats.
    Le Monnier de Gouville AC; Mondot S; Lippton H; Hyman A; Cavero I
    J Pharmacol Exp Ther; 1990 Jan; 252(1):300-11. PubMed ID: 2405151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium channel blockade of atrial negative inotropic responses to P1-purinoceptor and muscarinic receptor agonists and to cromakalim.
    Urquhart RA; Ford WR; Broadley KJ
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):279-88. PubMed ID: 7679163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cromakalim (BRL 34915) on hemodynamic and electrocardiographic changes induced by endothelin in dogs.
    Tsunetoshi T; Otsuka A; Mikami H; Katahira K; Moriguchi A; Ogihara T
    Basic Res Cardiol; 1991; 86(1):49-55. PubMed ID: 1850597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists.
    McPherson GA; Angus JA
    Br J Pharmacol; 1990 Jun; 100(2):201-6. PubMed ID: 2116201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin.
    Kaneta S; Yokoyama T; Izumi H; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):184-93. PubMed ID: 7979827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
    Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil.
    Longman SD; Clapham JC; Wilson C; Hamilton TC
    J Cardiovasc Pharmacol; 1988; 12(5):535-42. PubMed ID: 2468052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of the potassium channel openers cromakalim and pinacidil and the cromakalim analog U-89232 on isolated vascular and cardiac tissue.
    Norman NR; Toombs CF; Khan SA; Buchanan LV; Cimini MG; Gibson JK; Meisheri KD; Shebuski RJ
    Pharmacology; 1994 Aug; 49(2):86-95. PubMed ID: 7972325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular pharmacology of SKP-450, a new potassium channel activator, and its major metabolites SKP-818 and SKP-310.
    Shin HS; Seo HW; Yoo SE; Lee BH
    Pharmacology; 1998 Mar; 56(3):111-24. PubMed ID: 9532610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of the novel potassium channel opener UR-8225.
    Tamargo J; Pérez O; Delpón E; García-Rafanell J; Gómez L; Cavalcanti F
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):295-305. PubMed ID: 7475055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional hemodynamic dose-response of lemakalim and glybenclamide in anesthetized rats.
    Smits GJ; Perrone MH; Cox BF
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):49-56. PubMed ID: 9007670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.